{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:42:13Z","timestamp":1789004533519,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007088","name":"Jagiellonian University","doi-asserted-by":"publisher","award":["N41\/DBS\/000564"],"award-info":[{"award-number":["N41\/DBS\/000564"]}],"id":[{"id":"10.13039\/501100007088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In the course of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), the infiltration of lymphocytes and other inflammatory cells across the blood\u2013brain barrier is associated with interactions between adhesion molecules expressed by infiltrating cells and vascular endothelium. Monoclonal antibodies (mAb) against the \u03b14 subunit of \u03b14-\u03b21 integrin (VLA-4) show beneficial effects in both MS and EAE. (1) Background: The aim of this study was to examine the expression of selected adhesion molecules: VLA-4, VCAM-1, LFA-1, ICAM-1 and PECAM-1 in the successive phases of EAE and the effect of anti-VLA-4 mAb treatment on that expression. (2) Methods: EAE was induced in C57BL\/6 mice by immunization with MOG35\u201355 peptide. The animals were killed in three successive phases of the disease: onset (day 13), peak (day 18) and chronic (day 28). Frozen sections of the lumbar spinal cord were examined by quantitative immunofluorescence microscopy. The expression of the studied molecules was quantified as the percentage of the cross-sectioned spinal cord lesion area occupied by immunopositive structures. (3) Results: The expression of the studied molecules showed two temporal patterns: (1) an increase in the onset phase, a maximum in the peak phase and a decrease in the chronic phase, which corresponded to the temporal pattern of the clinical score, the number of lesions and the inflammation level (ICAM-1, LFA-1 and PECAM-1), and (2) an increase in the peak phase and no significant change or further increase in the chronic phase (VCAM-1, VLA-4). Among the molecules studied, ICAM-1 and LFA-1 exhibited the highest expression levels in the peak phase of EAE. Anti-VLA-4 mAb inhibited the expression of not only VLA-4 but also other adhesion molecules. (4) Conclusions: The interactions of adhesion molecules governing the migration of leukocytes across the blood\u2013brain barrier change in the successive phases of EAE. The therapeutic mechanism of anti-VLA-4 mAb treatment seems to include a complex influence on a variety of adhesion molecules expressed by infiltrating cells and vascular endothelium.<\/jats:p>","DOI":"10.3390\/ijms23094637","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T05:07:22Z","timestamp":1650604042000},"page":"4637","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Adhesion Molecule Profile and the Effect of Anti-VLA-4 mAb Treatment in Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5267-6374","authenticated-orcid":false,"given":"Gra\u017cyna","family":"Pyka-Fo\u015bciak","sequence":"first","affiliation":[{"name":"Department of Histology, Jagiellonian University Medical College, 31-034 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0467-8519","authenticated-orcid":false,"given":"Grzegorz J.","family":"Lis","sequence":"additional","affiliation":[{"name":"Department of Histology, Jagiellonian University Medical College, 31-034 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Litwin","sequence":"additional","affiliation":[{"name":"Department of Histology, Jagiellonian University Medical College, 31-034 Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410370404","article-title":"The adhesion molecule and cytokine profile of multiple sclerosis lesions","volume":"37","author":"Cannella","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-5728(94)90082-5","article-title":"Cell adhesion molecules on vessels during inflammation in the mouse central nervous system","volume":"51","author":"Engelhardt","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1357-4310(97)01066-6","article-title":"The role of adhesion molecules in multiple sclerosis: Biology, pathogenesis and therapeutic implications","volume":"3","author":"Archelos","year":"1997","journal-title":"Mol. Med. Today"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/01.WNL.0000158329.30470.D0","article-title":"Anti-alpha4 integrin therapy for multiple sclerosis: Mechanisms and rationale","volume":"64","author":"Rice","year":"2005","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10001","article-title":"Inhibition of LFA-1\/ICAM-1 and VLA-4\/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases","volume":"22","author":"Anderson","year":"2002","journal-title":"Med. Res. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fimmu.2019.00711","article-title":"PECAM-1 Stabilizes Blood-Brain Barrier Integrity and Favors Paracellular T-Cell Diapedesis Across the Blood-Brain Barrier during Neuroinflammation","volume":"10","author":"Wimmer","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood-2015-07-660092","article-title":"Structural basis for PECAM-1 homophilic binding","volume":"127","author":"Paddock","year":"2016","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrd1752","article-title":"Blocking adhesion molecules as therapy for multiple sclerosis: Natalizumab","volume":"4","author":"Steinman","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against a4b1 integrin","volume":"356","author":"Yednock","year":"1992","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/14740338.2017.1346082","article-title":"Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis","volume":"16","author":"Clerico","year":"2017","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_12","first-page":"265","article-title":"Effect of natalizumab treatment on metalloproteinases and their inhibitors in a mouse model of multiple sclerosis","volume":"71","author":"Lis","year":"2020","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI11717","article-title":"Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis","volume":"107","author":"Theien","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jnr.10487","article-title":"Differential efficacy of a synthetic antagonist of VLA-4 during the course of chronic relapsing experimental autoimmune encephalomyelitis","volume":"71","author":"Cannella","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: Experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2040-7378-1-5","article-title":"Models of autoimmune demyelination in the central nervous system: On the way to translational medicine","volume":"1","author":"Linker","year":"2009","journal-title":"Exp. Transl. Stroke Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.410340209","article-title":"Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1","volume":"34","author":"Archelos","year":"1993","journal-title":"Ann. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3389\/fimmu.2020.01884","article-title":"Regulatory B cells and its role in central nervous system inflammatory demyelinating diseases","volume":"11","author":"Ran","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5603\/FHC.a2018.0018","article-title":"Immunohistochemical analysis of spinal cord components in mouse model of experimental autoimmune encephalomyelitis","volume":"56","author":"Stasiolek","year":"2018","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_20","first-page":"408","article-title":"Lymphocyte adhesion and transendothelial migration in the central nervous system\u2014The role of LFA-1, ICAM-1, VLA-4 and VCAM-1","volume":"86","author":"Greenwood","year":"1995","journal-title":"Immunology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00005072-199902000-00004","article-title":"In Vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: Regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1","volume":"58","author":"Wong","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-5728(94)90239-9","article-title":"Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis","volume":"54","author":"Dopp","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1172\/JCI0213595","article-title":"Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1\u2013deficient mice","volume":"109","author":"Graesser","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_24","first-page":"23","article-title":"Adhesion-related molecules in the central nervous system. Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis","volume":"65","author":"Cannella","year":"1991","journal-title":"Lab. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0165-5728(03)00031-6","article-title":"Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE","volume":"136","author":"Ledeboer","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/(SICI)1097-4547(19960915)45:6<747::AID-JNR11>3.0.CO;2-T","article-title":"PECAM-1 (CD31) expression in the central nervous system and its role in experimental allergic encephalomyelitis in the rat","volume":"45","author":"Williams","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.178.2.851","article-title":"Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis","volume":"178","author":"Bullard","year":"2007","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.177.1.57","article-title":"Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma","volume":"177","author":"Baron","year":"1993","journal-title":"J. Exp. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1044-7431(03)00065-4","article-title":"Integrin alpha4beta1 (VLA-4) expression and activity in retinal and peripheral neurons","volume":"23","author":"Hikita","year":"2003","journal-title":"Mol. Cell Neurosci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1468-1331.2009.02532.x","article-title":"The effects of natalizumab on inflammatory mediators in multiple sclerosis: Prospects for treatment-sensitive biomarkers","volume":"16","author":"Khademi","year":"2009","journal-title":"Eur. J. Neurol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/9\/4637\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:58:42Z","timestamp":1760137122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/9\/4637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["ijms23094637"],"URL":"https:\/\/doi.org\/10.3390\/ijms23094637","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]}}}